Advanced Single Domain Antibody (SdAb) Discovery Service

Background SdAb Discovery Platform Application Advantage Related Services FAQ Online Inquiry

For over 20 years, Creative Biolabs has been at the forefront of antibody engineering and discovery. We have pioneered the development of robust platforms for identifying novel single domain antibodies (SdAbs)—the smallest functional antibody fragments—for clients in academic research, biotechnology, and pharmaceutical development worldwide. Our end-to-end services empower you to harness the extraordinary potential of SdAbs, from initial discovery to full-scale production and engineering. Leverage our deep expertise to discover high-affinity, highly stable single domain antibodies (also known as V_HH or V_NAR) tailored for your most demanding applications in therapeutics, diagnostics, and research.

Discuss Your Project Today

What are Single Domain Antibodies (SdAbs)?

Single Domain Antibodies are revolutionary antibody fragments derived from the heavy-chain-only antibodies (HCAbs) naturally found in camelids (like llamas and alpacas) and cartilaginous fish (like sharks). Comprising a single monomeric variable domain, either V_HH from camelids or V_NAR from sharks, SdAbs are a paradigm shift from conventional antibodies (e.g., IgG, Fab, scFv).

Fig. 1 A figure shows single domain antibodies from different camelid species. (Creative Biolabs Original). Fig. 1 Single domain antibodies from different camelid species.

Their compact structure, a mere 12-15 kDa, provides a multitude of advantages, making them superior candidates for a wide range of applications where traditional antibodies fall short.

Comparison: SdAb vs. Conventional Antibody Fragments

Feature	Single Domain Antibody (SdAb)	Conventional IgG	scFv Fragment	Fab Fragment
Origin	Camelid Heavy-Chain Antibody (V_HH) or Shark (V_NAR)	Mammalian	Engineered from IgG	Engineered from IgG
Size	~12-15 kDa	~150 kDa	~25-30 kDa	~50 kDa
Structure	Single Variable Domain	2 Heavy, 2 Light Chains	VH and VL linked	CH1-VH and CL-VL
Stability	Very High (Heat & pH resistant)	Moderate	Low (Prone to aggregation)	Moderate
Solubility	Excellent	Good	Often Poor	Good
Epitope Access	Excellent (Can access cryptic/hidden epitopes)	Limited to exposed epitopes	Moderate	Moderate
Production System	Microbial (E. coli, yeast)	Mammalian cells	Microbial (often with issues)	Microbial / Mammalian
Engineering	Simple (Ideal for multispecific formats)	Complex	Moderate	Moderate

Our State-of-the-Art SdAb Discovery Platforms

Creative Biolabs offers a comprehensive, multi-platform approach to SdAb discovery, ensuring we select the optimal strategy for your specific target and downstream application. Our integrated workflow is designed for maximum efficiency and success.

Integrated SdAb Discovery Workflow

Antigen Design & Immunization

Diverse Species: We immunize a wide range of camelids (llamas, alpacas, camels) or sharks to maximize immune response diversity.
Expert Immunization Protocols: Our proprietary adjuvants and immunization strategies are optimized for challenging targets, including membrane proteins (GPCRs, ion channels), small molecules, and toxins.

High-Quality Library Construction

We isolate peripheral blood mononuclear cells (PBMCs) from immunized animals to construct immune V_HH or V_NAR libraries.
Library diversity is meticulously controlled and can reach up to 1010, ensuring comprehensive coverage of the antibody repertoire.
Next-Generation Sequencing (NGS): We utilize NGS to perform deep sequencing analysis of the immune repertoire, providing critical insights into library quality and clonal diversity before screening.

Advanced Library Screening & Hit Identification

Phage Display Platform: Our primary workhorse for screening, capable of handling vast libraries to isolate high-affinity binders against purified proteins, cells, or other complex targets.
Yeast Display Platform: An alternative or complementary platform, ideal for quantitative screening and affinity maturation using Fluorescence-Activated Cell Sorting (FACS).
Cell-Based Panning: We perform screening directly on cells overexpressing your target of interest, ensuring the discovery of antibodies that recognize the native protein conformation.

Rigorous Hit Characterization & Validation

High-Throughput Sequencing & Analysis: We sequence hundreds of positive clones and use our bioinformatics pipeline to identify unique families of SdAb candidates.
Expression & Purification: Promising candidates are subcloned, expressed in E. coli or yeast, and purified for further analysis.
Binding Kinetics Analysis: Affinity and kinetics are precisely measured using state-of-the-art techniques like Surface Plasmon Resonance (SPR) or Bio-Layer Interferometry (BLI).
Functionality Assays: We perform custom-developed cellular or biochemical assays to confirm the functional activity of the lead SdAbs.

Comprehensive SdAb Discovery Strategies

Creative Biolabs provides tailored discovery strategies to meet your project's unique requirements for speed, specificity, and novelty.

Immune Camelid V_HH & Shark V_NAR Library Services

This is our premier service for discovering high-affinity binders with superior developability characteristics. By leveraging a robust in-vivo maturation process within the animal's immune system, this strategy consistently yields SdAbs with nanomolar or even picomolar affinities.

Ideal for: Therapeutic antibody discovery, challenging targets, projects requiring the highest possible affinity.
Timeline: 12-16 weeks.

Naïve & Synthetic SdAb Library Screening

For projects with tight timelines or against highly toxic/non-immunogenic targets, our pre-constructed naïve and synthetic SdAb libraries offer a powerful alternative. These large, diverse libraries can be screened immediately, bypassing the immunization step entirely.

Ideal for: Rapid discovery of binders, diagnostic reagent development, non-immunogenic targets.
Timeline: 4-6 weeks.

Custom SdAb Engineering and Optimization Services

Discovery is just the beginning. Our services extend to full-scale engineering to enhance your lead candidates for therapeutic or diagnostic use.

SdAb Humanization: Mitigate immunogenicity while retaining affinity and stability.
SdAb Affinity Maturation: Improve binding affinity into the low picomolar range.
Bispecific & Multispecific SdAb Construction: Engineer novel molecules that can engage multiple targets simultaneously.
SdAb-Drug Conjugates (ADCs): Develop next-generation targeted therapeutics.

Applications of Single Domain Antibodies

The unique properties of SdAbs have unlocked possibilities across numerous fields. We deliver discovery solutions optimized for your specific application.

Application Area	How SdAbs Provide a Unique Advantage
Therapeutics	Superior tissue penetration for solid tumors. Can be formulated for alternative delivery routes (e.g., inhalation). Ideal for constructing CAR-T cells and bispecific T-cell engagers.
Diagnostics	Exceptional stability for robust immunoassays (ELISA, LFIA). Small size allows for high-density sensor coating. Rapid, low-cost production for scalable kits.
Research Reagents	High-affinity tools for protein crystallization, immunoprecipitation (IP), and flow cytometry. Can be expressed intracellularly as "intrabodies" to modulate protein function.
Imaging Agents	Small size allows for rapid clearance and high tumor-to-background signal in in-vivo imaging.

Why Choose Creative Biolabs?

Unparalleled Expertise: With over two decades dedicated to antibody discovery, our Ph.D.-level scientists are true pioneers in the field of single domain antibodies.
Cutting-Edge Technology: We continuously invest in the latest platforms, including NGS, advanced display technologies, and high-throughput screening robotics, to ensure the highest quality outcomes.
Proven Track Record: We have successfully completed thousands of SdAb discovery projects for a global clientele, leading to numerous publications and patents.
End-to-End Solutions: From antigen design to GLP-grade production, we offer a seamless, one-stop solution to accelerate your research from concept to clinic-ready candidate.
Customized Project Design: We don't believe in a one-size-fits-all approach. We work closely with you to design a project plan that perfectly aligns with your scientific goals and budget.

Related Featured SdAb Discovery Services

Explore our specialized services to advance your research:

Our experts are ready to discuss your project and design a custom SdAb discovery strategy.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQ)

Q: What starting material do I need to provide?

A: You can provide the antigen in various forms: purified protein, synthetic peptide, plasmid DNA, or even cells overexpressing the target. Our team will guide you on the optimal format and quantity.

Q: What is the typical timeline for an immune library project?

A: A full project, from immunization to delivery of characterized SdAb sequences, typically takes between 12 and 16 weeks. Timelines can be expedited for certain projects.

Q: What species of camelids do you use?

A: We maintain our own animal facilities with llamas, alpacas, and dromedary camels, allowing us to select the best species for eliciting a strong immune response against your specific antigen.

Q: How do you ensure the discovered SdAbs will be functional?

A: Our screening strategies can be tailored to isolate functionally active antibodies. This includes panning on live cells to select for binders to native conformations and incorporating functional assays into the validation stage.

Reference

N'Guessan, Émilien, et al. "Enhancing theranostic potential of anti-mesothelin sdAb through site-specific labeling at a unique conserved lysine by molecular engineering." EJNMMI Radiopharmacy and Chemistry 10.1 (2025): 1-16. https://doi.org/10.1186/s41181-025-00340-z

×

Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.